GT Biopharma, Inc. (NASDAQ: GTBP) is a clinical stage immuno-oncology company focused on developing innovative therapies based on the Company's proprietary NK cell engager (TriKE™) technology. TriKE™ therapeutic agents are targeted immunotherapeutic agents that simultaneously react with natural killer (NK) cells and cancer cells to selectively facilitate the killing of cancer cells.
9350 Wilshire Blvd
Beverly Hills, CA 90212
Medical Diagnostics & Research
Pharmaceutical Preparation Manufacturing (325412)
Pharmaceutical Preparations (2834)